Unlock instant, AI-driven research and patent intelligence for your innovation.

Artalbic acid derivative composition for preparing acute renal failure resistant medicine

A technology of acute renal failure and composition, applied in the field of organic synthesis and medicinal chemistry, to achieve the effect of improving function

Inactive Publication Date: 2016-11-09
南京海澳斯生物医药科技有限公司
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

There are few clinical drugs that have obvious effects on improving renal blood perfusion disorder and reducing renal tissue damage

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Artalbic acid derivative composition for preparing acute renal failure resistant medicine
  • Artalbic acid derivative composition for preparing acute renal failure resistant medicine
  • Artalbic acid derivative composition for preparing acute renal failure resistant medicine

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0012] The preparation of embodiment 1 compound Artalbic acid

[0013] The preparation method of compound Artalbic acid (I) refers to the literature published by Antonella Maggio et al. (Antonella Maggio et al., 2011. Artalbic acid, a sesquiterpene with an unusual skeleton from Artemisia alba (Asteraceae) from Sicily. Tetrahedron Letters, 52 (2011) 4543–4545) approach.

[0014]

Embodiment 2

[0015] The synthesis of the O-bromoethyl derivative (II) of embodiment 2 Artalbic acid

[0016] Compound I (266 mg, 1.00 mmol) was dissolved in 10 mL of benzene, and tetrabutylammonium bromide (TBAB) (0.08 g), 1,2-dibromoethane (3.760 g, 20.00 mmol) and 6 mL of 50% sodium hydroxide solution. The mixture was stirred at 40 °C for 16 h. After 16 hours, the reaction solution was poured into ice water, extracted twice with dichloromethane immediately, and the organic phase solutions were combined. Then the organic phase solution was washed with water and saturated brine for 5 times successively, then dried with anhydrous sodium sulfate, and finally concentrated under reduced pressure to remove the solvent to obtain a crude product. The crude product was purified by silica gel column chromatography (mobile phase: petroleum ether / acetone=100:1.0, v / v), the brown concentrated elution band was collected and the solvent was evaporated to obtain a brown powder of Compound II (272mg, 73...

Embodiment 3

[0021] The synthesis of O-(dichloroethylamino) ethyl derivative (III) of embodiment 3 Artalbic acid

[0022] 1. Synthesis of O-(dihydroxyethylamino)ethyl derivatives of Artalbic acid

[0023] Compound II (187 mg, 0.5 mmol) was dissolved in 20 mL of acetonitrile, anhydrous potassium carbonate (690 mg, 5.0 mmol), potassium iodide (252 mg, 1.5 mmol) and diethanolamine (1051 mg, 10 mmol) were added thereto, and the mixture was heated to reflux for 1 h. After the reaction was completed, the reaction solution was poured into 20 mL of ice water, extracted three times with an equal amount of dichloromethane, and the organic phases were combined. The combined organic phases were successively washed with water and saturated brine, dried over anhydrous sodium sulfate, and concentrated under reduced pressure to remove the solvent to obtain a crude product. The crude product was purified by silica gel column chromatography (mobile phase: petroleum ether / acetone=100:1.0, v / v), and the yell...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses application of a composition of an O-(dichloroethylamino)ethyl and O-(di(2-methylmercaptoethyl)amido) ethyl derivative of artalbic acid to acute renal failure resistant medicine, and relates to the fields of organic synthesis and medicinal chemistry, in particular to a composition of an O-(dichloroethylamino)ethyl and O-(di(2-methylmercaptoethyl)amido) ethyl derivative of artalbic acid, a preparation method of the composition and a purpose of the composition to the preparation of acute renal failure resistant medicine. The invention discloses the composition of the O-(dichloroethylamino)ethyl and O-(di(2-methylmercaptoethyl)amido) ethyl derivative of the artalbic acid, and the preparation method of the composition. Pharmacological experiments show that the composition of the O-(dichloroethylamino)ethyl and O-(di(2-methylmercaptoethyl)amido) ethyl derivative of the artalbic acid has an acute renal failure resistant effect and a value for developing the acute renal failure resistant medicine.

Description

technical field [0001] The invention relates to the fields of organic synthesis and medicinal chemistry, in particular to a composition, a preparation method and an application thereof. Background technique [0002] Acute renal failure (Acute Renal Failure, ARF) is a clinical syndrome caused by a variety of reasons, which can be seen in patients of various clinical departments. It has a high incidence and often brings serious consequences. ) with a sharp decline in renal function, clinical manifestations of acute oliguria (urine output <400mLPd) or anuria (urine output <100mLPd), obstacles in the excretion of nitrogen metabolites in the body, rapid azotemia, water and electrolytes, acid-base Balance disorder, and cause the corresponding dysfunction of the system of the whole body. The main factors causing acute renal failure are the sharp reduction of renal blood flow, as well as the oxidative stress and cell damage caused by renal tissue ischemia, which eventually le...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/195A61P13/12C07C323/25C07C217/12
CPCA61K31/195C07C217/12C07C323/25A61K2300/00
Inventor 丁秋菊
Owner 南京海澳斯生物医药科技有限公司